RE:Bottom line on the merger:"Through the planned merger with Aeterna Zentaris, we aim to become a combined company with high potential for value creation in the biopharmaceutical industry. We look forward to an exciting future ahead for the Company and generating value in the short and long term for all stakeholders,” stated Gilles Gagnon, M.Sc., MBA, President and CEO." news release
Sure, look at the short and long term graphs of their stock prices and you'll know that's a bold faced lie.